300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Sudan
Guernsey
Cameroon
Andorra
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Health Care Startup Investors in Switzerland (September 2026)

The most active venture capital funds and angel investors investing in Switzerland Health Care startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Switzerland Health Care startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Foundation for Innovation and Technology (FIT)
VC Fund
63 Switzerland, France, United States Debt Financing, Grant, Seed Health Care, Biotechnology, Artificial Intelligence $20k–$2.5M
Zürcher Kantonal Bank
VC Fund
62 Switzerland, Germany, Japan Seed, Series A, Series B Health Care, Biotechnology, Medical Device $1M–$20M
Verve Ventures
VC Fund
49 Switzerland, Germany, France Series A, Seed, Series B Health Care, Software, Biotechnology $1.2M–$45M
SICTIC
VC Fund
28 Switzerland, Germany, Tanzania Seed, Pre-Seed Software, Artificial Intelligence, Information Technology $264k–$3.7M
BioMedPartners
VC Fund
18 Switzerland, Germany, France Series A, Series B, Series C Biotechnology, Health Care, Medical $5.3M–$75M
VI Partners
VC Fund
16 Switzerland, Germany, United States Series A, Series B, Series C Health Care, Biotechnology, Software $3.2M–$100M
Kickfund
VC Fund
15 Switzerland, France, Germany Seed, Pre-Seed, Convertible Note Health Care, Biotechnology, Manufacturing $110k–$5.7M
Bernina BioInvest
VC Fund
15 Switzerland Seed, Series A, Series B Biotechnology, Health Care, Medical $1.5M–$65M
M Ventures
VC Fund
14 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
redalpine
VC Fund
13 Germany, Switzerland, United Kingdom Seed, Series A, Series B Biotechnology, Health Care, Software $1.6M–$125M
HTGF (High-Tech Gruenderfonds)
VC Fund
13 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $850k–$31M
Eclosion SA
VC Fund
12 Switzerland Seed, Series C Biotechnology, Pharmaceutical, Health Care $1.6M–$28M
Versant Ventures
VC Fund
11 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $5M–$108M
Kinled Holding
VC Fund
10 United Kingdom, United States, Switzerland Seed, Series A Biotechnology, Health Care, Software $594k–$40M
Zühlke Ventures AG
VC Fund
10 Switzerland, Sweden, United States Series A, Seed, Series B Health Care, Medical Device, Medical $1.1M–$11M
4FOX Ventures
VC Fund
10 Switzerland, United States Series A, Seed, Series B Medical Device, Medical, Health Care $1.8M–$69M
Schroder Adveq
VC Fund
10 Switzerland, United States, India Series B, Series C, Series A Biotechnology, Health Care, Therapeutics $5M–$100M
StartAngels Network
VC Fund
10 Switzerland, Brazil Seed, Series A, Series B Health Care, Medical, Medical Device $933k–$5.7M
GoBeyond
VC Fund
10 Switzerland, Germany, United Kingdom Seed, Series A Software, Health Care, Information Technology $495k–$5M
Novartis Venture Fund
VC Fund
9 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$120M
OCCIDENT
VC Fund
9 Switzerland, Germany, Finland Series A, Seed, Series B Health Care, Biotechnology, Medical Device $758k–$139M
Swisscom Ventures
VC Fund
9 Switzerland, United States, United Kingdom Series B, Series A, Series C Software, SaaS, Information Technology $2M–$80M
Founderful
VC Fund
9 Switzerland, United Kingdom, Canada Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $810k–$24M
Joyance Partners
VC Fund
9 United States, Germany, Switzerland Seed, Series A, Pre-Seed Health Care, Biotechnology, Wellness $500k–$21M
Privilège Ventures
VC Fund
9 Switzerland, Italy, France Seed, Pre-Seed, Series A Health Care, Software, Wearables $667k–$7M
Polytech Ventures
VC Fund
8 Switzerland, United States, Spain Seed, Series A, Series B Software, Financial Services, FinTech $500k–$10M
3wVentures
VC Fund
8 Switzerland, Spain, Austria Seed, Angel, Series A Software, Health Care, Search Engine $50k–$8M
b2venture
VC Fund
8 Germany, Switzerland, United Kingdom Series A, Seed, Series B Software, Health Care, Information Technology $1.4M–$52M
Lichtsteiner Foundation
VC Fund
8 Switzerland Seed, Series A Biotechnology, Health Care, Medical $1.6M–$6.8M
S2S Ventures
VC Fund
8 Switzerland, Germany Pre-Seed, Seed Health Care, Artificial Intelligence, Manufacturing $28k–$3.4M
Alpana Ventures
VC Fund
8 United States, Switzerland, Germany Seed, Series A, Series B Software, FinTech, Health Care $729k–$45M
Novo Holdings
VC Fund
7 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9.5M–$135M
EQT Life Sciences
VC Fund
7 United States, The Netherlands, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7.3M–$165M
Sofinnova Partners
VC Fund
7 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
Fongit Seed Invest
VC Fund
7 Switzerland Seed, Series A, Series B Health Care, Medical, Biotechnology $1M–$3.3M
BlueOcean Ventures
VC Fund
7 Switzerland, India, France Seed, Series A, Series B Health Care, Medical, Personal Health $1M–$20M
Serpentine Ventures
VC Fund
7 Switzerland, Germany, United States Seed, Pre-Seed Software, Information Technology, Automotive $110k–$6.3M
Nina Capital
VC Fund
6 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $529k–$21M
DAA Ventures
VC Fund
6 Switzerland, France Seed, Series A, Venture - Series Unknown Software, Information Technology, Health Care $1.2M–$49M
FortyOne Group
VC Fund
6 Switzerland, Germany Seed, Series A, Venture - Series Unknown Software, Information Technology, Information Services $500k–$6.2M
Innosuisse
VC Fund
6 Switzerland, United States, United Kingdom Grant, Pre-Seed, Seed Health Care, Biotechnology, Medical Device $16k–$16M
Aglaia BioMedical Ventures
VC Fund
5 The Netherlands, United States, Switzerland Series A, Series B, Seed Biotechnology, Therapeutics, Pharmaceutical $5.5M–$23M
Broadview Ventures
VC Fund
5 United States, Switzerland, Canada Series A, Seed, Series B Health Care, Biotechnology, Medical Device $1M–$45M
Pureos Bioventures
VC Fund
5 France, Switzerland, United States Series A, Series B, Series C Biotechnology, Therapeutics, Medical $7.1M–$125M
Good Seed Ventures
VC Fund
5 Germany, Israel, United States Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Biotechnology $55k–$50M
Translink Capital
VC Fund
5 United States, China, South Korea Series A, Series B, Series C Software, Artificial Intelligence, Information Technology $4.1M–$58M
EIT Health
VC Fund
5 United Kingdom, Spain, Ireland Grant, Pre-Seed, Seed Health Care, Medical Device, Medical $27k–$1.7M
ETH Zurich Foundation
VC Fund
5 Switzerland Pre-Seed, Seed, Grant Medical, Software, 3D Printing $152k–$5.6M
Startfeld
VC Fund
5 Switzerland Seed, Grant, Pre-Seed Health Care, Wellness, Manufacturing $313k–$2.5M
Ralph Gygax
Angel
5 Switzerland Seed, Pre-Seed, Series A Cannabis, Wellness, Cosmetics $119k–$621k
Access all 1332 investors in Switzerland Health Care startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Foundation for Innovation and Technology (FIT)
VC Fund · Lausanne, Vaud, Switzerland · 63 investments in Switzerland Health Care startups, 31 in the past 12 months

The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Debt Financing, Grant, Seed
  • Geography: Switzerland, France, United States

Investor stats

  • Total investments: 257
  • Round size: Seed $100k–$2.5M; Grant $20k–$125k; Debt Financing $99k–$530k
  • Lead/follow: 93% lead, 7% follow

Portfolio highlights

  • SixtineAI — is an AI-driven clinical documentation and workflow assistant specifically designed for healthcare providers.
  • Nextrainers — Nextrainers is a sports technology company that provides AI-powered football training sessions, tactical analysis, and player progression.
  • Documenter AI — Complete AI copilot platform for enterprise project management, compliance automation, and business process automation. Deploy intelligent agents, automate workflows, and ensure compliance across all industries.
Show all investments...

Zürcher Kantonal Bank
VC Fund · Zürich, Zurich, Switzerland · 62 investments in Switzerland Health Care startups

Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Germany, Japan

Investor stats

  • Total investments: 205
  • Round size: Seed $1M–$6M; Series A $2.1M–$13M; Series B $1.9M–$20M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: Likely actively investing — fresh fund, raised $150M in 2024

Portfolio highlights

  • Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
  • QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
  • Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 49 investments in Switzerland Health Care startups, 11 in the past 12 months

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 301
  • Round size: Seed $1.2M–$11M; Series A $2.1M–$18M; Series B $3.9M–$45M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: Likely still investing — raised $61M in 2022

Portfolio highlights

  • Axelera AI — Axelera AI is a company that delivers purpose-built hardware and software platforms designed to accelerate artificial intelligence tasks, particularly in edge computing. The company's flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions.This platform has been recognized for its innovation, notably being named a CES® 2024 Innovation Awards Honoree.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies.
  • Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
  • Atana Elements — Atana is accelerating the exploration and development of flowing critical minerals and industrial gases. Atana uses a proprietary tech stack to identify and mature mineral resources quickly and effectively.
Show all investments...

SICTIC
VC Fund · Zürich, Zurich, Switzerland · 28 investments in Switzerland Health Care startups

SICTIC is the leading angel investor network in Switzerland with the largest Swiss seed-stage startup dealflow.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Switzerland, Germany, Tanzania

Investor stats

  • Total investments: 299
  • Round size: Seed $504k–$3.7M; Pre-Seed $264k–$2.7M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
  • Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
  • Ionic Wind Technologies — Ionic wind technologies, which use an internationally patented concept, alter the way airflow is generated. Instead of conventional rotating machinery, we move air with electric fields.
Show all investments...

BioMedPartners
VC Fund · Basel, Basel-Stadt, Switzerland · 18 investments in Switzerland Health Care startups

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 88
  • Round size: Series A $5.3M–$31M; Series B $5.3M–$75M; Series C $5.3M–$47M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $106M in 2018

Portfolio highlights

  • T-CURX — T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges ...
  • iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

VI Partners
VC Fund · Altendorf, Schwyz, Switzerland · 16 investments in Switzerland Health Care startups

Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Series C
  • Geography: Switzerland, Germany, United States

Investor stats

  • Total investments: 113
  • Round size: Series A $3.2M–$23M; Series B $3.3M–$41M; Series C $7M–$100M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $110M in 2020

Portfolio highlights

  • Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
  • Pay by Shopping (deal united) — paybyshopping.com Domain Name is available to Buy. Grab this great Domain from Daaz. Daaz has the lowest transaction fees in the industry. See our list of GTLD's,CCTLD's, New GTLD's,3N's, 6N's, 3L's, 6L's etc.
  • Sonic Emotion — Sonic Emotion Absolute 3DTM sound technology provides an innovative unique solution for an immersive natural 3D sound reproduction by implementing audio products with sound field control from only 2, 3, 4 or 6+ channels using a single compact device (and an optional subwoofer internal or external).
Show all investments...

Kickfund
VC Fund · Basel, Basel-Stadt, Switzerland · 15 investments in Switzerland Health Care startups, 15 in the past 12 months

Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: Switzerland, France, Germany

Investor stats

  • Total investments: 50
  • Round size: Seed $1.1M–$5.7M; Pre-Seed $335k–$4M; Convertible Note $110k–$118k
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — raised $80M in 2023

Portfolio highlights

  • Bewelab SA — Bewe is a mobile game designed to reduce cravings, using neuroscience to automatically retrain your brain and effortlessly reclaim your health.
  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
Show all investments...

Bernina BioInvest
VC Fund · Zug, Zug, Switzerland · 15 investments in Switzerland Health Care startups

Bernina BioInvest is an investment Firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland

Investor stats

  • Total investments: 16
  • Round size: Seed $1.5M–$20M; Series A $15M–$65M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
  • Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 14 investments in Switzerland Health Care startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 187
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Quintessent — Quintessent is developing optical connectivity solutions to scale computing and Artificial Intelligence (A.I.).
  • TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Show all investments...

redalpine
VC Fund · Zürich, Zurich, Switzerland · 13 investments in Switzerland Health Care startups, 19 in the past 12 months

redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: Germany, Switzerland, United Kingdom

Investor stats

  • Total investments: 201
  • Round size: Seed $1.6M–$13M; Series A $3.2M–$33M; Series B $16M–$125M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $200M in 2024

Portfolio highlights

  • microagi — Accelerating embodied AGI
  • telli — A world where every interaction is worth having. https://t.co/Qa65ENaxKL
  • Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 13 investments in Switzerland Health Care startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 739
  • Round size: Seed $850k–$7M; Series A $3.1M–$31M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
  • Alteva — Alteva develops battery cells for the decarbonisation of the global transport sector, and focus on high-energy density battery cells with high safety profiles specifically designed for the aviation and heavy-duty transport sectors.
  • Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
Show all investments...

Eclosion SA
VC Fund · Geneva, Geneve, Switzerland · 12 investments in Switzerland Health Care startups

Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Seed, Series C
  • Geography: Switzerland

Investor stats

  • Total investments: 16
  • Round size: Seed $1.6M–$2.7M; Series C $20M–$28M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • KYLYS — KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS provides people and patients with highly effective and safe products based on biomolecules.
  • Genkyotex — Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy, giving them a significant competitive advantage.Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.
  • MPC Therapeutics — MPC Therapeutics develops a novel class of compounds with application in Immunotherapy and Metabolic diseases
Show all investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 11 investments in Switzerland Health Care startups

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 324
  • Round size: Series A $5M–$78M; Series B $12M–$105M; Series C $12M–$108M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — raised $5M in 2024

Portfolio highlights

  • Inari Medical — Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. They are focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. It hasdeveloped two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.The company was founded in 2011 and is headquartered in Irvine, California.
  • Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
  • Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
Show all investments...

Kinled Holding
VC Fund · New York, New York, United States · 10 investments in Switzerland Health Care startups

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 143
  • Round size: Seed $594k–$14M; Series A $1.7M–$40M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
  • Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
  • TAG Therapeutics — TAG Therapeutics develops precision medicine approaches for telomere pathologies and aging-related diseases, such as Idiopathic Pulmonary Fibrosis and Short Telomere Syndromes
Show all investments...

Zühlke Ventures AG
VC Fund · Schlieren, Zurich, Switzerland · 10 investments in Switzerland Health Care startups

Zühlke Ventures AG is a venture capital arm of Zühlke Technology Group AG specializing in financing of start-ups at an early stage and providing growth capital. It seeks to invest in the technology and medical devices companies. It typically invests in German-speaking Europe and Great Britain.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Sweden, United States

Investor stats

  • Total investments: 15
  • Round size: Seed $1.1M–$3M; Series A $7M–$11M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • Bottneuro — Bottneuro strives to set new standards in personalized neuromodulation - achieving better results and improving quality of life. Find out more!
  • Indivi — Healios CTMS provides the Digital Biomarker based technology and digital validation scales to improve and streamline research and clinical practice.
  • PeriVision — At Perivision, we combine artificial intelligence (AI), virtual reality (VR) and the cloud to build the next generation systems to understand visual function. Our systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases.
Show all investments...

4FOX Ventures
VC Fund · Luxembourg, Luxembourg, Luxembourg · 10 investments in Switzerland Health Care startups

4FO Ventures

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, United States

Investor stats

  • Total investments: 23
  • Round size: Seed $1.8M–$3.3M; Series A $1.8M–$11M; Series B $5.5M–$69M
  • Lead/follow: 52% lead, 48% follow

Portfolio highlights

  • Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
  • Ecorobotix — ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs.
  • Neo Medical — Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems.
Show all investments...

Schroder Adveq
VC Fund · Zürich, Zurich, Switzerland · 10 investments in Switzerland Health Care startups

Schroders Capital provides investors with access to a broad range of private asset investment opportunities, portfolio building blocks and customised private asset strategies. With over $65 billion assets under management, we offer a diversified range of investment strategies, including real estate, private equity, secondaries, venture capital, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Series A
  • Geography: Switzerland, United States, India

Investor stats

  • Total investments: 36
  • Round size: Series A $5M–$22M; Series B $11M–$73M; Series C $15M–$100M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — raised $113M in 2020

Portfolio highlights

  • Bizongo — Bizongo is a Tech-Enabled B2B Platform for Packaging, Apparels & Other Customised Goods. We digitally transform vendor management & supply chain.
  • Lenskart — Lenskart, the first of its kind online optical store in India, has made it possible to acquire a good quality pair of specs with prescription lenses for just Rs. 399. With a 48-hour free home delivery guarantee and 365 days return policy, Lenskart.com is doing what e-commerce hasn’t been able to do in India yet.The website has over 500 designs ofeye frames, in multiple colors, for all age groups, from Rs. 399 all the way to Rs. 4,000 for a pair. All one needs to do is select a frame, fill in their power, and place an order. You can pay online or at the time of delivery.Lenskart.com has the biggest collection of discounted contact lenses consisting of all top-notch brands (viz. Johnson & Johnson, Bausch & Lomb, Ciba Vision to name a few) and be it disposable, toric, colored, or bifocal contact lenses, you can find all possible types here. Lenskart is dedicated to providing its customers with a simple, hassle-free way to replace their contact lenses. One can receive the exact same contact lens, their doctor prescribed, delivered to their door, at a great price.
  • Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
Show all investments...

StartAngels Network
VC Fund · Zürich, Zurich, Switzerland · 10 investments in Switzerland Health Care startups

StartAngels Network is a Zurich-based angel investment firm that provides investment consulting services.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Brazil

Investor stats

  • Total investments: 31
  • Round size: Seed $933k–$3.4M; Series A $2M–$3.5M; Series B $1.7M–$5.7M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Rflect — Rflect helps universities protect their business model in the age of AI by training the human skills machines cannot replace—reflection, resilience, collaboration—directly inside the curriculum for credit. As AI commoditizes knowledge and devalues degrees, Rflect secures degree value through measurable human development and audit-ready data foraccreditation, employability, and retention. Embedded as credit-bearing infrastructure, Rflect achieves 100% student usage, zero institutional churn, and long-term lock-in cycles.
  • Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
  • Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
Show all investments...

GoBeyond
VC Fund · Zürich, Zurich, Switzerland · 10 investments in Switzerland Health Care startups

GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: Switzerland, Germany, United Kingdom

Investor stats

  • Total investments: 190
  • Round size: Seed $495k–$5M; Series A $1.2M–$4.5M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Stylect — Stylect is a mobile app to to help women discover their perfect shoe. They aggregate products from multiple websites and based on users' preferences (that they gather through a hot-or-not interface), they recommend better products. Their users are able to keep track of and buy the products they like and receive notifications whenever a productthey love goes on sale. Finally, They use geolocation to let their users know when a shoe is selling in a store nearby.
  • LockStyler — LockStyler is a hair locks coloring device used by hairdressers for hair highlighting and lowlighting. It is composed of an applicator, cartridge, and base. LockStyler was launched in 2014 and is manufactured in Montreux, Switzerland.
  • Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 9 investments in Switzerland Health Care startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 230
  • Round size: Series A $5.1M–$85M; Series B $11M–$120M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
  • Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
  • Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
OCCIDENT
VC Fund · Zug, Zug, Switzerland · 9 investments in Switzerland Health Care startups

Occident is an international, privately held investment company based in Zug and Munich. Our goal is to manage our own wealth in a sustainable, meaningful manner seeking to make a positive contribution to society through our investments. Venture Capital is the focus of our investment activities. We see ourselves as a long-term oriented enabler forinnovative start-ups and visionary founders. As a complementary team of experts, we are fascinated by technologically sound topics (deep tech) from the life sciences, digital and high-tech sectors with the potential to decisively improve people's lives.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, Finland

Investor stats

  • Total investments: 39
  • Round size: Seed $758k–$4.6M; Series A $2.2M–$12M; Series B $5.5M–$139M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Show all investments...

Swisscom Ventures
VC Fund · Zürich, Zurich, Switzerland · 9 investments in Switzerland Health Care startups, 6 in the past 12 months

Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007.Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technicalexpertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services.Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: Switzerland, United States, United Kingdom

Investor stats

  • Total investments: 156
  • Round size: Series A $2M–$22M; Series B $2M–$60M; Series C $8.6M–$80M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $300M in 2022

Portfolio highlights

  • Apono — Apono makes permission management to applications, infrastructure, and data repositories simple, secure and compliant.
  • CDDS — CDDS is a defense technology firm producing AI-powered autonomous interceptor drones for countering unmanned aerial systems.
  • Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
Show all investments...

Founderful
VC Fund · Zürich, Zurich, Switzerland · 9 investments in Switzerland Health Care startups, 15 in the past 12 months

Founderful operates as a venture capital firm and a Switzerland’s leading pre-seed fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, United Kingdom, Canada

Investor stats

  • Total investments: 111
  • Round size: Seed $1.5M–$14M; Pre-Seed $810k–$4.3M; Series A $3M–$24M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: Likely still investing — raised $143M in 2024

Portfolio highlights

  • Fusionality — Fusionality is a Swiss fusion-technology company focused on measurement, control, and data systems for fusion devices.They combine expertise in fusion physics, control engineering, AI/ML, simulation, diagnostics, and real-time software.Their goal is to help fusion companies and research labs operate devices more efficiently and accelerate thedevelopment of commercial fusion energy.
  • Stellar Alpina — Stellar Alpina develops modular lunar landers and the RDRE propulsion modules that power them, combining rapid hardware iteration with a scalable platform approach for reliable missions from Earth orbit to the Moon.
  • Exclaim Robotics — Autonomous mobile robots for the AI data center.
Show all investments...

Joyance Partners
VC Fund · San Francisco, California, United States · 9 investments in Switzerland Health Care startups

Joyance Partners invests in companies that, through science and tech, cultivate joy to improve how we live, focusing on the health and consumer sectors from Pre-Seed to Series A.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Wellness
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 120
  • Round size: Seed $960k–$6M; Pre-Seed $500k–$2M; Series A $3.6M–$21M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • KilgourMD — Scalp Care is Self Care. A revolutionary two-step preventative and treatment system for scalp ageing and thick, healthy looking hair.
  • NOMU — NOMU provides the personalized drinking experience with its proprietary reusable cup drink machine.
  • Lucky Energy — LUCKY F*CK is a better-for-you energy drink company.
Show all investments...

Privilège Ventures
VC Fund · Zürich, Zurich, Switzerland · 9 investments in Switzerland Health Care startups

Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary over five decades of combined investment experience Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary Authentic, dedicated, disciplined, and goal-oriented, our team drives meaningful and lasting success About Team

Show more...

Investment focus

  • Industry: Health Care, Software, Wearables
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Switzerland, Italy, France

Investor stats

  • Total investments: 24
  • Round size: Seed $1M–$5.9M; Pre-Seed $667k–$1.6M; Series A $4.1M–$7M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $21M in 2022

Portfolio highlights

  • Xsensio — Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developedat the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
  • ENANTIOS — ENANTIOS specializes in creating benchtop analytical instruments that provide industries, research institutions, and academic facilities.
  • Develop Players — Supporto clinico per ADHD e DSA online. Aiutiamo adulti, bambini e ragazzi con screening, potenziamento e percorsi psicologici personalizzati.
Show all investments...

Polytech Ventures
VC Fund · Lausanne, Vaud, Switzerland · 8 investments in Switzerland Health Care startups

Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, United States, Spain

Investor stats

  • Total investments: 53
  • Round size: Seed $500k–$3.5M; Series A $2.1M–$10M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2016

Portfolio highlights

  • Relai — All you need to get started is to download our award winning Relai app, complete a simple verification and start buying with as little as 50 CHF/EUR.
  • Hemostod — Developing universal platelets and next-generation diagnostics
  • Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
Show all investments...

3wVentures
VC Fund · Herisau, Ausser-Rhoden, Switzerland · 8 investments in Switzerland Health Care startups

3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.

Show more...

Investment focus

  • Industry: Software, Health Care, Search Engine
  • Stage:Seed, Angel, Series A
  • Geography: Switzerland, Spain, Austria

Investor stats

  • Total investments: 42
  • Round size: Seed $50k–$3.5M; Angel $583k–$2.1M; Series A $1.2M–$8M
  • Lead/follow: 2% lead, 98% follow
  • Last fund: May invest from a new fund soon — raised $100M in 1999

Portfolio highlights

  • Abionic — Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from:
  • GUURU Solutions — Discover how community-powered advice can turn your PDPs into trusted, high-converting content and get cited in AI search.
  • Pregnolia — Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
Show all investments...

b2venture
VC Fund · Saint Gallen, Sankt Gallen, Switzerland · 8 investments in Switzerland Health Care startups

B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: Germany, Switzerland, United Kingdom

Investor stats

  • Total investments: 272
  • Round size: Seed $1.4M–$8.8M; Series A $3.4M–$23M; Series B $6.9M–$52M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fresh fund, raised $179M in 2026

Portfolio highlights

  • Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
  • Flyboard — Human-level AI voice agents at a fraction of the cost. Transform your customer engagement with intelligent automation.
  • Kiin Bio — Accelerate drug discovery with Virtual Scientists. Unified platform integrating 100+ specialized tools into one intelligent workflow.
Show all investments...

Lichtsteiner Foundation
VC Fund · Berne, Bern, Switzerland · 8 investments in Switzerland Health Care startups

Boosting health pioneers. We invest in early stage start-ups in different sectors: medtech, life science, biotech, mental health, public health, well-being.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 11
  • Round size: Seed $1.6M–$6.8M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Hemostod — Developing universal platelets and next-generation diagnostics
  • DigeHealth — DigeHealth combines a wearable acoustic sensor with your sleep, stress and nutrition data to reveal how your lifestyle affects your digestive health.
  • Allegria Therapeutics — Allegria Therapeutics is a Swiss biotech company targeting mast cells to redefine the treatment of allergic and inflammatory diseases.
Show all investments...

S2S Ventures
VC Fund · Zürich, Zurich, Switzerland · 8 investments in Switzerland Health Care startups

S2S Ventures is a fully student-led VC fund from Switzerland, backed by some of the country's most successful entrepreneurs.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Manufacturing
  • Stage:Pre-Seed, Seed
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 28
  • Round size: Seed $954k–$3.4M; Pre-Seed $28k–$2.7M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — raised $11M in 2021

Portfolio highlights

  • Haicker — AI code auditors. Cheaper than pentests, smart enough to spot your bad habits. Get Haicker now on https://t.co/rPLvJrB2jP
  • Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
  • Forgis — Forgis is leading the next industrial revolution by introducing industrial intelligence into factories, which boosts the competitiveness of Western manufacturing.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Alpana Ventures
VC Fund · Geneva, Geneve, Switzerland · 8 investments in Switzerland Health Care startups

Alpana Ventures is a Swiss VC focusing on digital transformation.Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact.Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US.We invest to embed them into innovative business models and back them tobecome global market leaders.Applying ESG criteria, our portfolio companies help create a more sustainable future.

Show more...

Investment focus

  • Industry: Software, FinTech, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, Switzerland, Germany

Investor stats

  • Total investments: 103
  • Round size: Seed $729k–$4M; Series A $2.1M–$14M; Series B $3M–$45M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Sinay — Sinay provides numerous solutions for maritime sector stakeholders, such as collecting and analysing maritime data.
  • Nezasa — Discover how to grow your business with Nezasa TripBuilder, the world's leading travel commerce solution for travel businesses.
  • Tinamu — Trusted inventory intelligence delivered in real-time
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 7 investments in Switzerland Health Care startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 398
  • Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Santaris Pharma — Spearheading RNA molecule research since 2003, our site in Copenhagen is focused on leading chemistry for targeting any type of transcribed RNA using short synthetic single-strand oligonucleotides. Here, our experts in the field pioneered our core technology platform of locked nucleic acids (LNA) and antisense oligonucleotides (ASO).
  • PTC Therapeutics — Translating Science. Transforming Lives.
  • SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Show all investments...

EQT Life Sciences
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 7 investments in Switzerland Health Care startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, The Netherlands, Switzerland

Investor stats

  • Total investments: 189
  • Round size: Series A $7.3M–$78M; Series B $11M–$114M; Series C $12M–$165M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $282M in 2023

Portfolio highlights

  • ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
  • Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
  • Rotation Medical — Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 7 investments in Switzerland Health Care startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 350
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

Fongit Seed Invest
VC Fund · Plan-les-ouates, Geneve, Switzerland · 7 investments in Switzerland Health Care startups

Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland

Investor stats

  • Total investments: 9
  • Round size: Seed $1M–$1.4M; Series A $2.3M–$3.3M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • EBAMed — EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
  • Gmelius — Gmelius is the world's first 360 email collaboration platform designed for Gmail and your company's daily apps. Join the async movement!
  • Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
Show all investments...

BlueOcean Ventures
VC Fund · Plan-les-ouates, Geneve, Switzerland · 7 investments in Switzerland Health Care startups

BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland. BlueOcean Ventures is based in Geneva, Switzerland.

Show more...

Investment focus

  • Industry: Health Care, Medical, Personal Health
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, India, France

Investor stats

  • Total investments: 17
  • Round size: Seed $1M–$3.1M; Series A $2.3M–$20M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Abionic — Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from:
  • Augurix — Augurix was born out of the real-life experiences of living with Celiac Disease. In 2004, Cecile – a pediatrician with an MD and PhD in immunology – noticed her 18-month old son Simon exhibiting symptoms of the disease. As a professional and having been diagnosed herself some thirty years earlier, she was able to spot the early warning signs. ButCecile was also acutely aware that despite affecting almost 1 in 100 people, Celiac Disease was difficult to diagnose.Cecile and her husband Thierry became determined to find a way to change this, giving parents and their children the best chance of an accurate diagnosis and the ability to live their lives free of the often debilitating symptoms. Using Swiss medical expertise Augurix was founded in 2007, with a mission to provide primary care doctors with an easy-to-use, affordable tool, to lower the hurdle of diagnostics.In 2010 Simtomax® was launched – a rapid screening test for the early determination of Celiac Disease at the point-of-care – finally bringing Cecile’s vision to life. Today, Augurix is pursuing its vision by enlarging its diagnostics offer to other gastrointestinal diseases.
  • official.fm — Music to discover and share.
Show all investments...

Serpentine Ventures
VC Fund · Zürich, Zurich, Switzerland · 7 investments in Switzerland Health Care startups

Serpentine Ventures (SERV) is the investment arm of the Swiss startup group. Serpentine refers to the meandering roads found across the Swiss Mountains. Unreachable mountain peaks become accessible by following the serpentine path.

Show more...

Investment focus

  • Industry: Software, Information Technology, Automotive
  • Stage:Seed, Pre-Seed
  • Geography: Switzerland, Germany, United States

Investor stats

  • Total investments: 88
  • Round size: Seed $1.1M–$6.3M; Pre-Seed $110k–$1.5M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Evulpo — Evulpo is a free learning website that provides an instructional videos, summaries, and practice units for curriculum-related topics. Evulpo provides assistance with all relevant curriculum in the primary, secondary, high school, and BMS levels.
  • Correntics — Our vision is to make global supply chains future-proof. With our data-driven approach, a deep understanding of risks, we help our clients to reduce risks in their value chains. Through our expertise, we support our clients to improve their operations and their financial resilience in the face of climate change and emerging risks while ensuring thesustainability of their business activities.
  • RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 6 investments in Switzerland Health Care startups, 11 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 96
  • Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $52M in 2025

Portfolio highlights

  • Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
  • Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
  • Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Show all investments...

DAA Ventures
VC Fund · Geneva, Geneve, Switzerland · 6 investments in Switzerland Health Care startups

DAA Capital Partners is a Swiss-based private equity generating significant returns on technology-driven companies and real estate opportunities

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Switzerland, France

Investor stats

  • Total investments: 31
  • Round size: Seed $1.2M–$4.8M; Series A $4.1M–$13M; Venture - Series Unknown $1.2M–$49M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Largo.ai — We make the data-driven movie-making accessible to the market through our high level film understanding technologies. Largo has developed data-driven intelligence, which can be introduced much earlier in the life of a film project, right from script choice and development, through filming, post-production and theatrical release. Largo empowersproduction companies with data-enhanced ROI uplift and reduction of risk.
  • Touch Sensity — Touch Sensity is an information technology company that specializes in the fields of IoT and sensors.
  • Cognitive Design Systems — Cognitive Design Systems (CDS) is a software company enabling designers and engineers to automate and accelerate their design process using AI. Our software converts concept designs into manufacturable, sustainable and economically viable products using machine learning algorithms.
Show all investments...

FortyOne Group
VC Fund · Ch'arants'avan, Kotayk', Armenia · 6 investments in Switzerland Health Care startups

At Fortyone AG they hold participations in non-listed companies. They are guided by the question: "Can they make a difference?". As active investors, they make investments in which, in addition to the financial resources, they can add value to their knowledge, their experience and their relationships. In order to live up to this smartmoney approach and to be able to actively influence the corporate design, they usually require the involvement of the Board of Directors. The scope of the participation depends on the requirements.

Show more...

Investment focus

  • Industry: Software, Information Technology, Information Services
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 25
  • Round size: Seed $500k–$5M; Series A $2.5M–$6.2M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Meteomatics — Meteomatics is a company that specializes in the specific IT needs of the weather, energy and trading industries. With more than 10 years of experience in the development of market leading forecasting systems and the rapid processing of weather data, they are happy to assist you with tailor-made solutions.
  • Catchfree — Catchfree uses a proprietary process to produce seafood substitutes that are appealing to consumers due to their excellent flavor, texture, appearance, and nutritious content.
  • memox. — Memox Innovations provides workshops, scheduling, and meeting spaces. Memox Innovations was founded in 2016 and is based in Zürich, Zürich.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Innosuisse
VC Fund · Berne, Bern, Switzerland · 6 investments in Switzerland Health Care startups, 11 in the past 12 months

Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Grant, Pre-Seed, Seed
  • Geography: Switzerland, United States, United Kingdom

Investor stats

  • Total investments: 236
  • Round size: Seed $500k–$16M; Grant $41k–$2.5M; Pre-Seed $16k–$4.3M
  • Lead/follow: 79% lead, 21% follow

Portfolio highlights

  • Actival — Actival is driven by innovation and the integration of AI tools in dentistry. It is committed to precision and oral health.
  • Precise Health — Why replace antibiotics when we can make them work better? AI reads the bacterial genome, matches the adjunct. Phages first.
  • BLEEDnFIRE Therapeutics — BLEEDnFIRE Therapeutics: At BLEEDnFIRE Therapeutics, we are pioneering innovative siRNA-based therapies for hemophilia, Von Willebrand disease & other rare bleeding disorders (RBDs) by developing BnF-001. Our mission is to transform patient care and improve quand improve quality of life through targeted ...
Show all investments...

Aglaia BioMedical Ventures
VC Fund · Bilthoven, Utrecht, The Netherlands · 5 investments in Switzerland Health Care startups

Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of tomorrow. As such, we are typically the first provider of capital for startup and early stage companies and a driving force behind product development. Since thenumber of technological discoveries in the biomedical field is growing fast, specialized knowledge regarding the translation of these discoveries into novel products is a prerequisite for success. Aglaia's focus on oncology is considered to be a differentiating asset. We invest in novel tools and technologies as well as components of contemporary drug development.Opportunities may be derived from research centers as well as from corporate spinouts. We select, develop and commercialize promising technologies up to a level where the technology becomes attractive to larger investors or pharmaceutical and biotech companies.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Pharmaceutical
  • Stage:Series A, Series B, Seed
  • Geography: The Netherlands, United States, Switzerland

Investor stats

  • Total investments: 13
  • Round size: Series A $5.5M–$17M; Series B $21M–$23M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $65M in 2014

Portfolio highlights

  • Inthera Bioscience — Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform. The company is headquartered in Zürich, Switzerland.
  • InteRNA Technologies — A Dutch clinical-stage biotech company InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation drug delivery
  • Sapreme Technologies — Enabling endosomal escape
Show all investments...

Broadview Ventures
VC Fund · Boston, Massachusetts, United States · 5 investments in Switzerland Health Care startups

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 83
  • Round size: Seed $1M–$18M; Series A $1M–$20M; Series B $7M–$45M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
  • Viridian Therapeutics (Formerly MiRagen Therapeutics) — Committed to developing potential best-in-class medicines for people affected by Thyroid Eye Disease and other autoimmune and rare diseases.
Show all investments...

Pureos Bioventures
VC Fund · Küsnacht, Zurich, Switzerland · 5 investments in Switzerland Health Care startups

Venture capital for companies developing innovative therapeutics.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, Switzerland, United States

Investor stats

  • Total investments: 36
  • Round size: Series A $12M–$123M; Series B $7.1M–$100M; Series C $22M–$125M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $205M in 2020

Portfolio highlights

  • NovaGo Therapeutics — NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics targeting cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. A strategic partnership with Neurimmune provides access to a unique class of human-derived antibodies with exceptional therapeutic propertiesgenerated through their Reverse Translational Medicine™ (RTM™) technology platform.
  • Tavo Biotherapeutics — Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
  • PulseSight Therapeutics — PulseSight is an ophthalmology drug development company creating novel, non-viral gene therapies with minimally invasive delivery technology to address the unmet need for treatments against severe retinal diseases leading to blindness.
Show all investments...

Good Seed Ventures
VC Fund · Rheine, Nordrhein-Westfalen, Germany · 5 investments in Switzerland Health Care startups

Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, Israel, United States

Investor stats

  • Total investments: 39
  • Round size: Seed $55k–$7M; Series A $7.5M–$50M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
  • Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Show all investments...

EIT Health
VC Fund · Munich, Bayern, Germany · 5 investments in Switzerland Health Care startups

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Grant, Pre-Seed, Seed
  • Geography: United Kingdom, Spain, Ireland

Investor stats

  • Total investments: 106
  • Round size: Seed $220k–$1.4M; Grant $27k–$1.6M; Pre-Seed $45k–$1.7M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • IDOVEN — Idoven has developed the world’s first AI cardiologist -Willem- that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale through APIs. The company counts clients such as AstraZeneca, Abbott, Novartis, GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation.Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, EIC Accelerator, Horizon 2020, ERC and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the the European Seal of Excellence 3x from the European Commission, granted by Horizon 2020, European Research Council ERC 2x (RIA) Europe’s most prestigious research grant, supporting excellent researchers in carrying out ground-breaking, high-risk, high-gain, frontier research projects, EIC Accelerator, and EIT Health. Idoven was ranked #1 Spanish HealthTech company in 2020 by NEOTEC. Idoven has been Google for Startups Resident at Google Campus Madrid and part of the Google for Startups Global Alumni Program. The company has won the prize Emprendedor XXI from CaixaBank, the Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine, and has been awarded at South Summit 2021 as the Most Disruptive Startup, and Best Health and Wellbeing Startup. Selected by CB Insights as one of the top 150 global companies in Digital Health for 2022, and top 50 global companies in Digital Health for 2023. Idoven was recognized by TIME Magazine as one of the World's Top HealthTech Companies of 2025.
  • Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
  • Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Show all investments...

ETH Zurich Foundation
VC Fund · Zürich, Zurich, Switzerland · 5 investments in Switzerland Health Care startups

ETH Zurich Foundation is an independent, non-​profit-making foundation under private law for the promotion of education and research at ETH Zurich.

Show more...

Investment focus

  • Industry: Medical, Software, 3D Printing
  • Stage:Pre-Seed, Seed, Grant
  • Geography: Switzerland

Investor stats

  • Total investments: 22
  • Round size: Seed $1.1M–$5.6M; Grant $152k–$175k; Pre-Seed $473k–$4.4M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Soverli — Soverli is a cybersecurity technology firm that provides advanced protection technologies for smartphones.
  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • Tethys Robotics — Tethys Robotics develops AI-powered application oriented robotics system that enables professionals in carrying underwater search & recovery to inspection & surveillance.
Show all investments...

Startfeld
VC Fund · Saint Gallen, Sankt Gallen, Switzerland · 5 investments in Switzerland Health Care startups

Startfeld is the innovation and start-up network in the St.GallenBodenseeArea. In every phase of innovation, they support both ambitious entrepreneurs and established SME, who are open to new impulses and development.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Manufacturing
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Switzerland

Investor stats

  • Total investments: 11
  • Round size: Seed $313k–$2.5M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Re-Nut — Re-Nut is a food processing company that engages in farming, production, and supply of Hazelnut based products.
  • Catchfree — Catchfree uses a proprietary process to produce seafood substitutes that are appealing to consumers due to their excellent flavor, texture, appearance, and nutritious content.
  • Ionic Wind Technologies — Ionic wind technologies, which use an internationally patented concept, alter the way airflow is generated. Instead of conventional rotating machinery, we move air with electric fields.
Show all investments...

Ralph Gygax
Angel · Bachenbülach, Zurich, Switzerland · 5 investments in Switzerland Health Care startups

Ralph Gygax is a Chief Administrative Officer at SWISS Gate AG. He attended KV, SVIT from 1999 to 2007.

Show more...

Investment focus

  • Industry: Cannabis, Wellness, Cosmetics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 5
  • Round size: Seed $119k–$621k
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • SWISS Gate AG — SWISS Gate AG is a family-run Swiss company founded in November 2019 by brothers Dominic, Marco & Michael Hoffmann with the support of their father Werner Hoffmann and uncle Ralph Gygax.SWISS Gate AG focuses with its positioning on the areas of Lifestyle & Wellbeing. The offered product assortment ranges from CBD Anti-Aging and Day Creamsto Skin Creams as well as Shampoo, Shower Gel or Conditioner to Hemp Foods like Hemp Tea or Hemp Seed Oils to CBD Hemp Flowers to CBD Hemp Oil for humans and animals.SWISS Gate AG exclusively distributes its products of the company-owned brands Herbalea and Old Donald's through selected resellers as well as through the company-owned e-commerce channel cbuy.ch - Alles Gute aus Cannabis.SWISS Gate AG manufactures all products together with exclusive partners from the cosmetics, food & consumer goods industry and has the exclusive production & distribution rights over the products.SWISS Gate AG has launched its Series A financing round in mid-September 2021 with the goal to raise CHF 5'000'000. Currently, CHF 200,000 of this amount has been raised. The financing round is currently open - interested parties can contact CEO Marco Hoffmann directly via the contact details.
Show all investments...

Health Care Investor funding in Switzerland at a glance

Stats across 2k deals from 1.3k investors.

1.3k
investors
in Switzerland Health Care startups
2k
deals
in Switzerland Health Care startups
$1.1M
median round
in Switzerland Health Care startups
48%
lead investors
lead at least one round
32%
Grant
most common funding stage
87/13
VC / Angel
share of investor count

Access all 1332 investors in Switzerland Health Care startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Health Care Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 1332 investors investing in Switzerland Health Care startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists